PATENT CLAIM ANALYSIS

Application Number: 16122482
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "254050"]

Abstract:
Disclosed herein are methods of treating a brain tumor by administering Plinabulin. Some embodiments relate to treatment of glioblastoma multiforme by administering Plinabulin.

Claim (Index 8):
The method of  claim 7 , wherein the additional therapeutic agent is selected from the group consisting of temozolomide, bevicizumab, everolimus, carmustine, lomustine, procarbazine, vincristine, irinotecan, cisplatin, carboplatin, methatrexate, etoposide, vinblasatine, bleomycin, actinomycin, cyclophosphamide, and ifosfamide.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 97.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15555956', '15555963', '15028376', '15996945', '15835566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7611111590884143
- 35 USC 102 Novelty (BERT): 0.5272745173158403
- Combined Prediction Score: 0.7377274949111569
- Mean Citation Score: 209.205178
- Max Citation Score: 315.06485
- Similarity Product: 242.20742174635825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test